Phase 1 Leptomeningeal Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

HER2-positive Breast CancerLeptomeningeal DiseaseLeptomeningeal Metastasis

H. Lee Moffitt Cancer Center and Research Institute39 enrolled2 locationsNCT04588545

Recruiting

Phase 1

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

Leptomeningeal Disease

H. Lee Moffitt Cancer Center and Research Institute18 enrolled3 locationsNCT05809752